← back to search

Rachel Eguia

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, COVID-19 Clinical Research Studies, and SARS-CoV-2 detection and testing.
h-index
17
citations
3,835
works
32
NIH funding
primary concept
email

Recent publications

Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin
Cell Host & Microbe 2024cited by 38position: middledoi
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
Cell 2022cited by 97position: middledoi
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
PLoS Pathogens 2022cited by 79position: middledoi
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
Viruses 2022cited by 39position: middledoi
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
PLoS Pathogens 2022cited by 28position: middledoi
A human coronavirus evolves antigenically to escape antibody immunity
PLoS Pathogens 2021cited by 249position: firstdoi
Comprehensive Profiling of Mutations to Influenza Virus PB2 That Confer Resistance to the Cap-Binding Inhibitor Pimodivir
Viruses 2021cited by 16position: middledoi
Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays v2
2021cited by 1position: middledoi
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Cell Host & Microbe 2020cited by 1,143position: middledoi
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Viruses 2020cited by 888position: middledoi
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The Journal of Infectious Diseases 2020cited by 280position: middledoi
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
Nature Communications 2020cited by 75position: middledoi
Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays v1
2020cited by 2position: middledoi
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
eLife 2019cited by 139position: middledoi
Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans
eLife 2019cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jesse D. Bloom · Fred Hutch Cancer Center15 papers (2019–2024)Katharine H. D. Crawford · University of Washington7 papers (2020–2021)Andrea N. Loes · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa7 papers (2020–2024)Adam S. Dingens · Fred Hutch Cancer Center6 papers (2020–2021)Helen Y. Chu · Seattle Pacific University6 papers (2020–2022)Jennifer K. Logue · World Wide Web Consortium4 papers (2020–2022)Allison J. Greaney · Fred Hutch Cancer Center4 papers (2020–2022)David Veesler · Howard Hughes Medical Institute4 papers (2020–2022)Neil P. King · University of Washington4 papers (2020–2022)Deleah Pettie · University of Washington3 papers (2020–2020)Alexander L. Greninger · University of Washington3 papers (2020–2024)Janet A. Englund · Seattle Pacific University3 papers (2020–2024)Caitlin R. Wolf · University of New Mexico3 papers (2020–2020)Terry Stevens‐Ayers · Fred Hutch Cancer Center3 papers (2019–2022)Tyler N. Starr · University of Utah3 papers (2020–2022)Trevor Bedford · Fred Hutch Cancer Center3 papers (2019–2024)Nicholas Franko · University of Washington2 papers (2022–2022)Keara D. Malone · Seattle University2 papers (2020–2021)Michael Boeckh · Fred Hutch Cancer Center2 papers (2019–2021)Khadija Khan · Aligarh Muslim University2 papers (2022–2022)